+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advanced Drug Delivery Systems Global Market Opportunities and Strategies to 2033

  • PDF Icon

    Report

  • 358 Pages
  • April 2024
  • Region: Global
  • The Business Research Company
  • ID: 5954531
This report describes and explains the advanced drug delivery systems market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global advanced drug delivery systems market reached a value of nearly $259.24 billion in 2023, having grown at a compound annual growth rate (CAGR) of 6.2% since 2018. The market is expected to grow from $259.24 billion in 2023 to $373.4 billion in 2028 at a rate of 7.6%. The market is then expected to grow at a CAGR of 8.7% from 2028 and reach $566.44 billion in 2033.

Growth in the historic period resulted from the increased pharmaceutical research and development (R&D) expenditure, growing use of telemedicine services and rising healthcare expenditure. Factors that negatively affected growth in the historic period were product recalls.

Going forward, rising prevalence of chronic diseases, surging shift toward personalized medicine, increasing demand for early diagnosis of health problems and increasing growth in elderly population will drive the growth. Factor that could hinder the growth of the advanced drug delivery systems market in the future include risk of needlestick injuries.

The advanced drug delivery systems market is segmented by type into oral drug delivery system, injection-based drug delivery system, inhalation/pulmonary drug delivery system, transdermal drug delivery system, transmucosal drug delivery system, carrier-based drug delivery system and other types. The oral drug delivery system market was the largest segment of the advanced drug delivery systems market segmented by type, accounting for 39.9% or $103.46 billion of the total in 2023. Going forward, it is expected to be the fastest growing segment in the advanced drug delivery systems market segmented by type, at a CAGR of 9% during 2023-2028.

The advanced drug delivery systems market is segmented by application into oncology, anti-infective, central nervous system, respiratory diseases, cardiovascular diseases, musculoskeletal disorders, metabolic disorders and other applications. The other applications market was the largest segment of the advanced drug delivery systems market segmented by application, accounting for 19.2% or $49.86 billion of the total in 2023. Going forward, the oncology segment is expected to be the fastest growing segment in the advanced drug delivery systems market segmented by application, at a CAGR of 9.9% during 2023-2028.

The advanced drug delivery systems market is segmented by end user into hospitals, specialized clinics and other end users. The hospitals market was the largest segment of the advanced drug delivery systems market segmented by end user, accounting for 51.9% or $134.65 billion of the total in 2023. Going forward, the other end users segment is expected to be the fastest growing segment in the advanced drug delivery systems market segmented by end user, at a CAGR of 7.9% during 2023-2028.

The advanced drug delivery systems market is segmented by carrier type into liposomes, nanoparticles, microspheres, monoclonal antibodies and other carrier types. The nanoparticles market was the largest segment of the advanced drug delivery systems market segmented by carrier type, accounting for 28% or $72.58 billion of the total in 2023. Going forward, it is expected to be the fastest growing segment in the advanced drug delivery systems market segmented by carrier type, at a CAGR of 8.7% during 2023-2028.

The advanced drug delivery systems market is segmented by technology into prodrug, implants and intrauterine devices, targeted drug delivery, polymeric drug delivery and other technologies. The targeted drug delivery market was the largest segment of the advanced drug delivery systems market segmented by technology, accounting for 31.4% or $81.48 billion of the total in 2023. Going forward, it is expected to be the fastest growing segment in the advanced drug delivery systems market segmented by technology, at a CAGR of 8.7% during 2023-2028.

North America was the largest region in the advanced drug delivery systems market, accounting for 40% or $103.62 billion of the total in 2023. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the advanced drug delivery systems market will be Asia Pacific and Western Europe where growth will be at CAGRs of 8% and 7.8% respectively. These will be followed by North America and Eastern Europe where the markets are expected to grow at CAGRs of 7.6% and 6.5% respectively.

The global advanced drug delivery systems market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 2.91% of the total market in 2022. The market concentration can be attributed to the presence of large number of players in different geographies. Prominent players are acquiring the products and entering into partnerships with the other companies to consolidate their market positions across the globe, while others are distributing products. Johnson & Johnson, Inc was the largest competitor with a 0.50% share of the market, followed by Baxter with 0.48%, Becton, Dickinson and Company with 0.46%, Medtronic Plc with 0.31%, Pacira BioSciences, Inc. with 0.26%, Abbvie, Inc. with 0.24%, Gilead Sciences, Inc. with 0.20%, Merck KGaA with 0.17%, Danaher Corporation with 0.14% and Bausch Health Companies Inc with 0.14%.

The top opportunities in the advanced drug delivery systems market segmented by type will arise in the oral drug delivery system segment, which will gain $56.07 billion of global annual sales by 2028. The top opportunities in the advanced drug delivery systems market segmented by application will arise in the oncology segment, which will gain $28.36 billion of global annual sales by 2028. The top opportunities in the advanced drug delivery systems market segmented by end user will arise in the hospitals segment, which will gain $58.53 billion of global annual sales by 2028. The top opportunities in the advanced drug delivery systems market segmented by carrier type will arise in the nanoparticles segment, which will gain $37.65 billion of global annual sales by 2028. The top opportunities in the advanced drug delivery systems market segmented by technology will arise in the targeted drug delivery segment, which will gain $42.22 billion of global annual sales by 2028. The advanced drug delivery systems market size will gain the most in the USA at $37.87 billion.

Market-trend-based strategies for the advanced drug delivery systems market include introducing preclinical drug development with advanced drug delivery technology, increasing focus dissolving microneedle drug delivery methods, innovative on-body delivery systems for subcutaneous therapies, pioneering advanced drug delivery with thin film formulation and strategic partnerships and collaborations among market players to drive innovation and expansion in the market.

Player-adopted strategies in the advanced drug delivery systems market include expanding operations by new drug developments/approvals, expanding operations through acquisitions, expanding operations through innovations and expanding operations through strategic acquisitions.

To take advantage of the opportunities, the analyst recommends the advanced drug delivery systems companies to focus on advancing preclinical drug development with innovative technology, focus on dissolving microneedle drug delivery methods, focus on on-body delivery systems for subcutaneous therapies, focus on technological advancements in drug delivery, focus on oral and inhalation drug delivery systems, focus on targeted drug delivery and polymeric drug delivery, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships for brain-targeted drug delivery, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, focus on tailored solutions for end-users and focus on hospitals segment.

Table of Contents

1 Executive Summary
1.1 Advanced Drug Delivery Systems - Market Attractiveness and Macro economic Landscape
2 Table of Contents3 List of Tables4 List of Figures5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Advanced Drug Delivery Systems Market Definition and Segmentations
6.4 Market Segmentation by Type
6.4.1 Oral Drug Delivery System
6.4.2 Injection-Based Drug Delivery System
6.4.3 Inhalation/Pulmonary Drug Delivery System
6.4.4 Transdermal Drug Delivery System
6.4.5 Transmucosal Drug Delivery System
6.4.6 Carrier-Based Drug Delivery System
6.4.7 Other Types
6.5 Market Segmentation by Carrier Type
6.5.1 Liposomes
6.5.2 Nanoparticles
6.5.3 Microspheres
6.5.4 Monoclonal Antibodies
6.5.5 Other Carrier Types
6.6 Market Segmentation by Technology
6.6.1 Prodrug
6.6.2 Implants and Intrauterine Devices
6.6.3 Targeted Drug Delivery
6.6.4 Polymeric Drug Delivery
6.6.5 Other Technologies
6.7 Market Segmentation by Application
6.7.1 Oncology
6.7.2 Anti-Infective
6.7.3 Central Nervous System
6.7.4 Respiratory Diseases
6.7.5 Cardiovascular Diseases
6.7.6 Musculoskeletal Disorders
6.7.7 Metabolic Disorders
6.7.8 Other Application
6.8 Market Segmentation by End User
6.8.1 Hospitals
6.8.2 Specialized Clinics
6.8.3 Other End Users
7 Major Market Trends
7.1 Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
7.2 Increasing Focus Dissolving Microneedle Drug Delivery Methods
7.3 Innovative on-Body Delivery Systems for Subcutaneous Therapies
7.4 Pioneering Advanced Drug Delivery With Thin Film Formulation
7.5 Strategic Partnerships and collaborations Among Market Players to Drive Innovation and Expansion in the Market
8 Advanced Drug Delivery Systems Market - Macro Economic Scenario
8.1 COVID-19 Impact on the Advanced Drug Delivery Systems Market
8.2 Impact of the War in Ukraine on the Advanced Drug Delivery Systems Market
8.3 Impact of High Inflation on the Advanced Drug Delivery Systems Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
9.2.1 Market Drivers 2018 - 2023
9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 - 2028
9.3.2 Market Restraints 2023 - 2028
10 Global Advanced Drug Delivery Systems Market Segmentation
10.1 Global Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Advanced Drug Delivery Systems Market, Segmentation by Carrier Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.5 Global Advanced Drug Delivery Systems Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Advanced Drug Delivery Systems Market, Regional and Country Analysis
11.1 Global Advanced Drug Delivery Systems Market, by Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Advanced Drug Delivery Systems Market, by Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Advanced Drug Delivery Systems Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.1 Western Europe Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.2 Western Europe Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Advanced Drug Delivery Systems Market: Country Analysis
13.5 UK Market
13.6 UK Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.7 UK Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 Germany Market
13.10 Germany Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 France Market
13.14 France Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 Italy Market
13.18 Italy Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Spain Market
13.22 Spain Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Advanced Drug Delivery Systems Market: Country Analysis
14.6 Russia Market
14.7 Russia Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Advanced Drug Delivery Systems Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Advanced Drug Delivery Systems Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Advanced Drug Delivery Systems Market, Segmentation by Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Advanced Drug Delivery Systems Market, Segmentation by Application, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Advanced Drug Delivery Systems Market, Segmentation by End User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profile
19.2 Johnson & Johnson
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial overview
19.3 Baxter
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Becton, Dickinson and Company
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Medtronic Plc
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Pacira BioSciences, Inc.
19.6.1 Company Overview
19.6.2 Products and Services
19.6.3 Financial Overview
20 Advanced Drug Delivery Systems Market Other Major and Innovative Companies
20.1 Abbvie, Inc.
20.1.1 Company Overview
20.1.2 Products and Services
20.1.3 Business Strategy
20.2 Gilead Sciences, Inc.
20.2.1 Company Overview
20.2.2 Products and Services
20.2.3 Business Strategy
20.3 Merck KGaA
20.3.1 Company Overview
20.3.2 Products and Services
20.3.3 Business Strategy
20.4 Danaher Corporation
20.4.1 Company Overview
20.4.2 Products and Services
20.5 Bausch Health Companies Inc
20.5.1 Company Overview
20.5.2 Products and Services
20.5.3 Business Strategy
20.6 Evonik Industries AG
20.6.1 Company Overview
20.6.2 Products and Services
20.6.3 Business Strategy
20.7 Ypsomed Holding AG
20.7.1 Company Overview
20.7.2 Products and Services
20.7.3 Business Strategy
20.8 SHL Medical AG
20.8.1 Company Overview
20.8.2 Products and Services
20.8.3 Business Strategy
20.9 West Pharmaceutical Services, Inc
20.9.1 Company Overview
20.9.2 Products and Services
20.9.3 Business Strategy
20.10 Novo Nordisk a/S
20.10.1 Company Overview
20.10.2 Products and Services
20.10.3 Business Strategy
20.11 Purdue Pharma LP
20.11.1 Company Overview
20.11.2 Products and Services
20.12 Luye Pharma Group Ltd.
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Ipsen Biopharmaceuticals, Inc
20.13.1 Company Overview
20.13.2 Products and Services
20.13.3 Business Strategy
20.14 Sun Pharmaceutical Inc
20.14.1 Company Overview
20.14.2 Products and Services
20.14.3 Business Strategy
20.15 Takeda Pharmaceutical Company Limited
20.15.1 Company Overview
20.15.2 Products and Services
21 Competitive Benchmarking22 Competitive Dashboard
23 Key Mergers and Acquisitions
23.1 Cordis Corporation Acquired MedAlliance SA
23.2 DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
23.3 LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
23.4 SHL Medical Acquired LCA Automation AG
23.5 Halozyme Therapeutics Inc Acquired Antares Pharma Inc
23.6 Nemera Acquired Copernicus
24 Opportunities and Strategies
24.1 Global Advanced Drug Delivery Systems Market in 2028 - Countries Offering Most New Opportunities
24.2 Global Advanced Drug Delivery Systems Market in 2028 - Segments Offering Most New Opportunities
24.3 Global Advanced Drug Delivery Systems Market in 2028 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Advanced Drug Delivery Systems Market, Conclusions and Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 About the Analyst
26.6 Copyright and Disclaimer

Executive Summary

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033 provides the strategists; marketers and senior management with the critical information they need to assess the global advanced drug delivery systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies based on local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description

Where is the largest and fastest-growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider advanced drug delivery systems market; and compares it with other markets.

The report covers the following chapters:

  • Introduction And Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by carrier type, by technology, by application and by end user.
  • Key Trends: Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario: The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the advanced drug delivery systems market.
  • Global Market Size And Growth: Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis: Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation: Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by carrier type, by technology, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: Details on the company profiles of other major and innovative companies.
  • Competitive Benchmarking: Briefs on the financials comparison between major players in the market
  • Competitive Dashboard: Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section includes recommendations for advanced drug delivery systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System And Other Types.
2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types.
3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies.
4) By Application: Oncology; Anti-Infective; Central Nervous System; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications.
5) By End User: Hospitals; Specialized Clinics; Other End Users

Key Companies Mentioned: Johnson & Johnson, Inc; Baxter; Becton, Dickinson And Company; Medtronic Plc; Pacira Biosciences, Inc

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; advanced drug delivery systems indicators comparison.

Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • Johnson & Johnson, Inc
  • Baxter
  • Becton, Dickinson and Company
  • Medtronic Plc
  • Pacira BioSciences, Inc
  • Abbvie, Inc
  • Gilead Sciences Inc
  • Merck KGaA
  • Danaher Corporation
  • Bausch Health Companies Inc
  • Sun Pharma Advanced Research Company (SPARC)
  • Gufic Biosciences Ltd
  • Lonza
  • Fosun Pharma (Fosun International)
  • Luye pharma
  • Acino Pharma AG
  • MedAlliance SA
  • AstraZeneca
  • Mundipharma
  • Evonik Industries AG
  • SHL Medical AG
  • Bayer AG
  • Bristol Myers Squibb
  • Amgen Inc
  • Gilead Sciences, Inc
  • Eli Lilly and Company
  • Biogen Inc
  • Ache Laboratorios Farmaceuticos
  • Eurofarma Laboratorios EMS S.A
  • Cristalia Produtos Quimicos Farmaceuticos Ltd
  • Libbs Farmaceutica Ltd
  • Laboratorios Richmond S.A.C.I.F
  • Gador S.A
  • Roemmers S.A.C.I.F.A
  • Laboratorio Elea Phoenix andromaco S.A
  • Biosano Laboratorios
  • Laboratorios Recalcine
  • Laboratorios Procaps
  • Laboratorios Vita
  • Laboratorios Lafrancol
  • Laboratorios Quifar
  • Laboratorio Franco Colombiano LAFRANCOL
  • Laboratorios Bago del Peru
  • Laboratorios Pharmabiotics
  • Laboratorios Raffo
  • Eitan Medical Limited
  • Sorrel Medical
  • Boehringer Ingelheim United Arab Emirates
  • SHL Medical
  • Fertin Pharma A/S
  • Boston Scientific Corporation
  • Kindeva Drug Delivery L.P

Methodology

Loading
LOADING...

Table Information